text stringlengths 0 197k |
|---|
Participants will complete one research visit in which they will be enrolled and told which group they will be in- "Her Health Program" group or "Usual Care" group. If they are placed in the "Her Health Program" group, they will receive their usual care + the addition of an extra healthcare team member(called a communi... |
Researchers will compare those who receive the Her Health Program and those who do not receive the program to see if the Her Health Program can help women get healthcare in the first year after having a baby. conditions: Postpartum conditions: Pregnancy Related studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZE... |
<|newrecord|> nctId: NCT06298201 id: IMAGINE2024 briefTitle: E-Based Physical Exercise in Patients With Multiple Sclerosis and Comorbidity acronym: COMPACT overallStatus: RECRUITING date: 2024-04 date: 2024-11 date: 2025-07 date: 2024-03-07 date: 2024-03-07 name: University of Southern Denmark class: OTHER briefSummary... |
Aims: To assess the effect of e-based PE in addition to usual care in pwMS on clinical outcome and the levels of inflammatory, metabolic, and neurodegenerative mediators. Furthermore, to determine whether PE plays a role in the modification of comorbidities with a focus on vascular comorbidity and related risk factors,... |
Method: This study will be prospective with longitudinal follow-up of pwMS with and without comorbidities. The physical activity of pwMS will be measured at baseline and after six months by accelerometers. In a randomized controlled trial (RCT) patients will be randomly assigned in a 1:1 ratio to receive either usual c... |
Conclusion: This study will contribute to the rehabilitation and improved quality of life of pwMS particularly of patients with comorbidities. The potential for e-based PE at home to encourage sustained exercise engagement among pwMS will be evaluated, offering a significant contribution to the field of digital healthc... |
<|newrecord|> nctId: NCT06298188 id: RisaKids briefTitle: Risankizumab in Children With Crohn's Disease (RisaKids) overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2026-10 date: 2026-10 date: 2024-03-07 date: 2024-03-07 name: Shaare Zedek Medical Center class: OTHER briefSummary: The goal of this observational stu... |
This is a 1-year prospective multi-center cohort study of children commencing on risankizumab for pediatric CD with 2 years extension for long-term follow-up. The investigators will record clinical manifestations, blood markers and fecal calprotectin, with monitoring for safety signals including infusion and injection ... |
<|newrecord|> nctId: NCT06298175 id: 2021-157 briefTitle: Self-Management Training With Online Intervention Process for Young Adults With Chronic Conditions overallStatus: COMPLETED date: 2021-04-15 date: 2021-04-15 date: 2021-08-15 date: 2024-03-07 date: 2024-03-07 name: Saglik Bilimleri Universitesi class: OTHER brie... |
<|newrecord|> nctId: NCT06298162 id: 2018-1279 briefTitle: Assessment of Pouch Emptying With MRI After Roux-en-Y Gastric Bypass acronym: MRI pouch overallStatus: COMPLETED date: 2019-07-25 date: 2020-02-01 date: 2020-02-01 date: 2024-03-07 date: 2024-03-07 name: Rijnstate Hospital class: OTHER briefSummary: A cross-sec... |
<|newrecord|> nctId: NCT06298149 id: 2023-650-EXEMPT id: 1U54CA280812-01 type: NIH link: https://reporter.nih.gov/quickSearch/1U54CA280812-01 briefTitle: Reach Through Equitable Implementation of Turtle Island Tales overallStatus: ENROLLING_BY_INVITATION date: 2023-11-01 date: 2028-04-30 date: 2028-04-30 date: 2024-03-... |
<|newrecord|> nctId: NCT06298136 id: 15610923 briefTitle: The Effects of an Online Mindfulness-based Intervention for Children With Attention-Deficit/Hyperactivity Disorder acronym: MindADHD overallStatus: RECRUITING date: 2024-02-01 date: 2026-12-31 date: 2026-12-31 date: 2024-03-07 date: 2024-03-07 name: The Hong Kon... |
<|newrecord|> nctId: NCT06298123 id: adjuvant-03 briefTitle: Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelling overallStatus: COMPLETED date: 2019-02-01 date: 2023-02-01 date: 2023-02-01 date: 2024-03-07 date: 2024-03-07 name: Chen Xiaoping class: OTHER bri... |
<|newrecord|> nctId: NCT06298110 id: PRP in Abdominal hysterectomy briefTitle: The Effect of PRP on Wound Healing in High Risk Patients Undergoing Abdominal Hysterectomy overallStatus: NOT_YET_RECRUITING date: 2024-03-10 date: 2024-08-25 date: 2024-09-25 date: 2024-03-07 date: 2024-03-08 name: Helwan University class: ... |
<|newrecord|> nctId: NCT06298097 id: 2019.11 briefTitle: Brain Connectivity Measured With High-density Electroencephalography acronym: NEUROCONN overallStatus: RECRUITING date: 2020-06-11 date: 2025-02-02 date: 2025-02-02 date: 2024-03-07 date: 2024-03-07 name: IRCCS San Camillo, Venezia, Italy class: OTHER briefSummar... |
<|newrecord|> nctId: NCT06298084 id: 2023-505925-15-00 id: 2023/3668 type: OTHER domain: CSET number briefTitle: Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression ... |
The first 2 modules will evaluate: i. safety and efficacy of HER3-DXd with olaparib in patients with HER2-low and HER2-positive ABC progressed on T-DXd (Module 1) and HER3-DXd monotherapy in patients with HER2-low ABC progressed on T-DXd (Module 0). |
The main objective of Part 1 is to assess the safety and tolerability of HER3-DXd monotherapy and combination and to determine the recommended phase 2 dose (RP2D) of the combination containing HER3-DXd. |
The main objective of Part 2 is to assess the efficacy of study therapies in each module based on investigator assessment as evaluated by the objective response rate (ORR) at 6 months. conditions: Breast Cancer Metastatic conditions: HER2-positive Metastatic Breast Cancer conditions: HER2 Low Breast Carcinoma condition... |
<|newrecord|> nctId: NCT06298071 id: SIBP-R002-Ib briefTitle: A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout. overallStatus: RECRUITING date: 2023-03-03 date: 2024-12-30 date: 2025-12-30 date: 2024-03-07 date: 2024-03-07 name: Shanghai Institute Of Biological ... |
<|newrecord|> nctId: NCT06298058 id: SIBP-A13-I briefTitle: A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients. overallStatus: NOT_YET_RECRUITING date: 2024-03-12 date: 2026-04-30 date: 2026-06-30 date: 2024-03-07 date: 2024-03-07 name: Shanghai Institute Of Biological Pr... |
<|newrecord|> nctId: NCT06298045 id: DIM-06790-002 briefTitle: Effectiveness of a Combination of Trimetazidine With One Hemodynamic Agent in Patients Recently Diagnosed With Stable Angina and Still Symptomatic Despite First Line Hemodynamic Therapy overallStatus: RECRUITING date: 2023-07-15 date: 2025-03-31 date: 2025-... |
<|newrecord|> nctId: NCT06298032 id: 000414 briefTitle: A Study Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Persons overallStatus: RECRUITING date: 2024-02-20 date: 2024-11-12 date: 2024-11-12 date: 2024-03-07 date: 2024-03-07 name: Ferring Pharmaceuticals class:... |
<|newrecord|> nctId: NCT06298019 id: 73464 briefTitle: Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2027-04 date: 2039-04 date: 2024-03-07 date: 2024-03-07 name: Stanford University class: OTHER briefSummary: The goal of this clinical trial is t... |
The main questions the study intends to answer are: |
* Understanding how well patients tolerate undergoing this therapy in terms of side effects; |
* Getting an early idea if this therapy can help certain aspects of the autoimmune disease, including inflammation in the skin, muscles, and lungs; conditions: Dermatomyositis studyType: INTERVENTIONAL phases: PHASE1 allocation: NA interventionModel: SEQUENTIAL interventionModelDescription: Patients will be enrolled in... |
<|newrecord|> nctId: NCT06298006 id: 275025 briefTitle: A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients acronym: PASC24 overallStatus: RECRUITING date: 2022-02-22 date: 2026-12-31 date: 2027-06-30 date: 2024-03-07 date: 2024-03-07 name: Region Örebro County cl... |
<|newrecord|> nctId: NCT06297993 id: WIND-PSC-01 briefTitle: Adult Patients With Primary Sclerosing Cholangitis acronym: WIND-PSC overallStatus: RECRUITING date: 2024-04 date: 2029-01 date: 2031-01 date: 2024-03-07 date: 2024-04-09 name: Arbor Research Collaborative for Health class: OTHER briefSummary: Develop an appr... |
<|newrecord|> nctId: NCT06297980 id: 23-1513 briefTitle: Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes acronym: MERIT overallStatus: RECRUITING date: 2024-03-15 date: 2026-10-31 date: 2026-10-31 date: 2024-03-07 date: 2024-03-07 name: University of Colorado, Denver class: OTHE... |
<|newrecord|> nctId: NCT06297967 id: CSAPG-33 briefTitle: Acetic Acid 2% Solution for Skin Ulcers acronym: ECA-AA overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2026-04 date: 2026-06 date: 2024-03-07 date: 2024-03-12 name: Consorci Sanitari de l'Alt Penedès i Garraf class: OTHER briefSummary: The objective of th... |
Participants will be randomly assigned to receive either the acetic acid solution treatment or the standard current treatment. conditions: Ulcer, Skin studyType: INTERVENTIONAL phases: PHASE3 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count:... |
<|newrecord|> nctId: NCT06297954 id: GA22-00011 briefTitle: Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding overallStatus: RECRUITING date: 2023-03-16 date: 2024-06 date: 2024-06 date: 2024-03-07 date: 2024-03-07 name: Universidad Autonoma de Nuevo Leon class: OTHER b... |
<|newrecord|> nctId: NCT06297941 id: REM-422-102 briefTitle: Study of REM-422 in Patients With AML or Higher Risk MDS overallStatus: NOT_YET_RECRUITING date: 2024-04-15 date: 2026-03-15 date: 2027-06-15 date: 2024-03-07 date: 2024-04-23 name: Remix Therapeutics class: INDUSTRY briefSummary: The goal of this study is to... |
<|newrecord|> nctId: NCT06297928 id: 2023/11238/I briefTitle: Metabolomics and Bariatric Surgery in Patients With Metabolically Unhealthy Obesity overallStatus: RECRUITING date: 2024-01-01 date: 2025-06-01 date: 2026-12-31 date: 2024-03-07 date: 2024-03-07 name: Parc de Salut Mar class: OTHER briefSummary: The goal of ... |
* Can metabolic markers predict the transition from metabolically unhealthy obesity to metabolically healthy obesity after bariatric surgery? |
* How do metabolic profiles change in individuals with metabolically healthy obesity after bariatric surgery? |
* What are the metabolic differences between individuals with metabolically healthy and unhealthy obesity before and after bariatric surgery? |
Participants will undergo routine evaluations and blood tests before and after bariatric surgery. These tests will include assessments of metabolic health markers and sampling of blood plasma for metabolomic analysis. The study will study changes in metabolic profiles between individuals who transition to metabolically... |
<|newrecord|> nctId: NCT06297915 id: 2022/08-45 briefTitle: Infusion Treatments of Chronic Peripheral Neuropathic Pain overallStatus: COMPLETED date: 2022-05-17 date: 2023-05-10 date: 2023-08-01 date: 2024-03-07 date: 2024-03-07 name: Hacettepe University class: OTHER briefSummary: This study aimed to evaluate and comp... |
Patients who received intravenous ketamine infusion and the other patient group who received intravenous lidocaine infusion were evaluated in the study. Pain scores and quality of life were assessed with scales before treatment at two weeks, two months, and six months after treatment. conditions: Neuropathic Pain study... |
<|newrecord|> nctId: NCT06297902 id: 2023_31 briefTitle: RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3 acronym: RADPAINT-3 overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2027-06 date: 2030-06 date: 2024-03-07 date: 2024-03-07 name: Oslo Univ... |
The RADPAINT-3 trial includes a translational sub-study where we aim to elucidate underlying mechanisms related to the radiotherapy effect, by investigating blood samples. Analysis of cytokines in repetitive blood samples may predict both tumor response and toxicity. The data derived from this sub-study, will be furthe... |
If RADPAINT-3 shows that there is no excess toxicity, we will continue the study after a new protocol has been approved. The new primary endpoint will be local control at 1 year after radiotherapy. Power analysis show that we will need in total 182 evaluable patients including the 100 patients from RADPAINT-3. The tran... |
<|newrecord|> nctId: NCT06297889 id: Ma Hucheng briefTitle: Effect of Core Strength Training on the Physical Fitness and Skills of Youth Field Hockey Players in China overallStatus: RECRUITING date: 2024-02-15 date: 2024-06-01 date: 2024-06-15 date: 2024-03-07 date: 2024-03-08 name: Universiti Putra Malaysia class: OTH... |
Against this backdrop, modern-day hockey programs have metamorphosed into rigorous and demanding training regimes. Athletes engaged in these programs are required not only to demonstrate outstanding physical fitness but also exhibit a high level of proficiency in the nuanced skills essential for competitive play. As ho... |
Despite the growing emphasis on the physical and skill dimensions of hockey, a literature review uncovered a dearth of research specifically focusing on core strength training for hockey players. While core strength training has demonstrated efficacy in improving physical fitness and skill performance among athletes in... |
To address this research gap, the present study sought to investigate the effects of core strength training on the physical fitness and skill performance of youth hockey players in Gansu Province, China. By doing so, this study not only contributes valuable insights to the existing body of literature but also furnishes... |
<|newrecord|> nctId: NCT06297876 id: H00023815 briefTitle: COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color overallStatus: RECRUITING date: 2023-05-19 date: 2024-05 date: 2025-05 date: 2024-03-07 date: 2024-03-07 name: University of Massachusetts, Worcester class: OTHER nam... |
<|newrecord|> nctId: NCT06297863 id: DOWN-SUITE briefTitle: Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke acronym: DOWN-SUITE overallStatus: NOT_YET_RECRUITING date: 2024-10-01 date: 2026-09-30 date: 2026-12-31 date: 2024-03-07 date: 2024-03-07 name: University of Milano Bicocca class: OTHER n... |
This study will involve adult patients who are eligible for mechanical thrombectomy and who have acute ischemic stroke due to left or right middle cerebral artery occlusion (M1 segment). |
The investigators hypothesise that HDT15, applied in acute ischemic stroke patients with a large vessel occlusion, will improve collateral circulation, prolong the survival of the ischemic penumbra and improve the clinical benefit from mechanical thrombectomy compared with standard of care (usual positioning 0° to +30°... |
<|newrecord|> nctId: NCT06297850 id: WARD-Glucose Validation v.2.2 briefTitle: Accuracy of Continuous Glucose Monitoring in Patients With Diabetes. A Prospective Observational Study overallStatus: RECRUITING date: 2024-04-01 date: 2024-09-30 date: 2025-05-01 date: 2024-03-07 date: 2024-04-12 name: University Hospital B... |
The main questions it aims to answer are: |
• Do CGM measurements have a decreased accuracy compared to standard blood glucose measurements in periods with circulatory impairment? |
Participants will be asked to wear a blinded CGM device (Dexcom G7, Dexcom Inc.) during their stay in the hospital but will receive standard care of their diabetes. The CGM device will be worn for up to 10 days. conditions: Diabetes Mellitus conditions: Dysglycemia conditions: Perioperative Complication conditions: Cir... |
<|newrecord|> nctId: NCT06297837 id: LHS0205 briefTitle: ADAPT-AST (Adaptive Antimicrobial Susceptibility Testing) acronym: ADAPT-AST overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2025-12 date: 2026-03 date: 2024-03-07 date: 2024-03-07 name: Liverpool University Hospitals NHS Foundation Trust class: OTHER_GOV b... |
* Can the investigators use a method called Bayesian causal inference to create or check clinical prediction models that help predict if certain antibiotics will work for a urinary infection, using patient information from the National Health Service (NHS)? |
* Can this new ADAPT-AST method, which uses data and a smarter approach, do a better job of testing for urinary infection than the old methods? Will it help doctors make quicker decisions and save resources by being more efficient? |
Participants in this study will not be receiving treatments. The study will involve: |
Using statistical methods to predict UTI test results based on patient data. Evaluating whether this new approach can provide doctors with more timely and useful information for treating UTIs. |
Assessing whether it can help save money and resources in the lab and pharmacy. conditions: Urinary Tract Infections studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: RETROSPECTIVE count: 500000 type: ESTIMATED measure: The number of antimicrobial susceptibility results that 'should' spur action by a ... |
<|newrecord|> nctId: NCT06297824 id: 2023-04909-01 briefTitle: Feasibility of Emotion Regulation Group Therapy for Adolescent Self-Harm acronym: ERGT-A overallStatus: RECRUITING date: 2023-10-10 date: 2024-12-31 date: 2025-06-30 date: 2024-03-07 date: 2024-03-07 name: Karolinska Institutet class: OTHER briefSummary: De... |
A quantitative feasibility open trial (N=20) followed up by a qualitative interview study will examine the feasibility, acceptability and preliminary effect of ERGT for adolescents. conditions: Self-harm conditions: Emotion Regulation conditions: Adolescent - Emotional Problem studyType: INTERVENTIONAL phases: NA alloc... |
<|newrecord|> nctId: NCT06297811 id: SMA PT 001 briefTitle: Myeloprotection With Trilaciclib in Pan-cancer Population overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2025-09-30 date: 2027-12-31 date: 2024-03-07 date: 2024-03-07 name: Sun Yat-sen University class: OTHER briefSummary: The goal of this open-label... |
* effect and safety of trilaciclib on myeloprotection in cancer patients receiving paclitaxel plus carboplatin chemotherapy |
* does trilaciclib 's myeloprotective efficacy in patients receiving the same chemotherapy regimen correlate with tumor type |
Participants will be randomized 2:1 to the treatment arm of trilaciclib in combination with a paclitaxel and carboplatin-based regimen and the control arm of a paclitaxel and carboplatin-based regimen for at least 6 cycles or until disease progression or intolerable toxicity. Patients in both groups could extend the ch... |
<|newrecord|> nctId: NCT06297798 id: SakaryaAppliedSciencesUPNS briefTitle: Effects of Telerehabilitation-Based Interventions on the Musculoskeletal System in Drivers overallStatus: NOT_YET_RECRUITING date: 2024-03-14 date: 2024-03-21 date: 2024-05-10 date: 2024-03-07 date: 2024-03-15 name: Sakarya Applied Sciences Uni... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.